Would you please start by giving a brief overview of BCG-unresponsive NMIBC? Nonmuscle Invasive Bladder Cancer Prior to recent therapeutic innovations in the bladder space what challenges or unmet ...
Please review the standard treatment options (intravesical chemotherapy, PD-L1 inhibitors, other immunotherapeutic options) currently available for patients with BCG-unresponsive NMIBC.
"This idea that physicians and medical teams always feel that they need to be available at all hours of the day really starts to stress people." says Chad W. M. Ritenour, MD, FACS. In this video, Chad ...
"The interplay between the microbiome and bladder cancer is very complex," says Ilaha Isali, MD, MSc. Isali: The interplay between the microbiome and bladder cancer is very complex. There is still ...
CMS issued a J-code for Anktiva, effective January 1, 2025, aiding billing and reimbursement processes for intravesical therapies. Anktiva, approved by the FDA in April 2024, is used with BCG for ...
“It's a good problem to have, because we're thinking about a previous era in which we didn't have many options besides more BCG vs cystectomy,” says Vikram M. Narayan, MD. In this video, Vikram M.
Bayer seeks approval in China for darolutamide plus ADT for mHSPC, marking a potential third indication. The ARANOTE trial showed darolutamide plus ADT significantly improved rPFS and OS compared to ...
Spina bifida patients frequently have bacteria in their urinary microbiomes, challenging the notion of sterile urine and complicating UTI diagnosis. E. coli is a dominant organism in the microbiomes ...
Quiz: CUA guidelines on germline genetic testing in prostate cancer ...
Quiz: CUA guidelines on germline genetic testing in prostate cancer ...
"You don't want to go into anything blind. You want to make sure that the numbers make sense," says Gia Ching. In this video, Amy M. Pearlman, MD, interviews Gia Ching of GCC Consulting regarding what ...
“Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing new therapeutic strategies ...